Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival
Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent study. Although the procedure, also known as HITHOC, has yet to be proven effective in a randomized clinical trial – and still is being debated by mesothelioma specialists – the report has elevated its status as a potentially useful adjuvant. “We concluded that the heated chemotherapy, delivered in a specialty center, has shown benefit,” researcher Alan G. Dawson told The Mesothelioma Center at Asbestos.com. “It...
Source: Asbestos and Mesothelioma News - May 3, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Pleural Treatment Source Type: news

United Kingdom Proposes 40-Year Asbestos Removal Deadline
The United Kingdom’s Work and Pensions Committee has proposed a 40-year timeline to complete the regulated removal of all long-standing legacy asbestos from public and commercial buildings, potentially setting a new standard for other nations to follow. Its proposal was recently delivered to the House of Commons with a recommendation that the government and Health and Safety Executive incorporate the findings into their approach to asbestos management. The U.K. already is one of more than 60 nations in the world to have banned asbestos, but none have passed this type of regulation for legacy asbestos, which has bee...
Source: Asbestos and Mesothelioma News - April 28, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Source Type: news

Peritoneal Mesothelioma HIPEC Program Comes to Alabama
Patients in Alabama diagnosed with peritoneal mesothelioma cancer no longer need to leave the state in pursuit of optimal care and long-term survival. The best possible mesothelioma treatment is now closer to home. The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham recently launched a complex treatment program for several abdominal malignancies that combines extensive cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, also known as HIPEC. This combination, used only at select specialty centers throughout the U.S., has been especially effective for peritoneal mesothe...
Source: Asbestos and Mesothelioma News - April 21, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Treatment Source Type: news

UNISON welcomes asbestos report
UNSON has broadly welcomed today’s report from the work and pensions committee, which calls for a deadline for the removal of asbestos in all public buildings. With cancers related to asbestos – including mesothelioma – remaining one of the biggest causes of work-related deaths in the UK, the committee highlighted the risk of disturbing the material and exposing workers to it when retrofitting buildings in response to net zero plans around energy efficiency. It also reported on a woeful lack of inspection and enforcement activity by the Health and Safety Executive. The committee made a number of recommendations...
Source: UNISON meat hygiene - April 21, 2022 Category: Food Science Authors: Amanda Kendal Tags: Article News asbestos health and safety Source Type: news

Johnson & Johnson Bankruptcy Plan Won ’t Halt Industrial Talc Lawsuit
Johnson & Johnson may have used a controversial bankruptcy spinoff to avoid almost 40,000 cosmetic talc lawsuits, but it now must face plaintiffs harmed by industrial talcum powder decades ago. U.S. federal Judge Michael Kaplan ruled earlier this month that the recent bankruptcy plan halting the majority of cases would not apply to this latest class-action lawsuit. The ruling in a New Jersey Superior Court stems from a complaint first brought in 1986. A man claimed his lung disease was caused by asbestos exposure linked to contaminated talc at his job at Windsor Minerals, a mine in Vermont owned by Johnson & ...
Source: Asbestos and Mesothelioma News - April 19, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Legal Source Type: news

Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor recurrence. History has proven that an incentive for a repeat surgery is there. A recent 30-year retrospective review at Wake Forest Baptist Medical Center has shown how beneficial the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, or HIPEC, can be for several cancers with peritoneal metastasis. “People often think it’s a one-and-done procedure,” Wake Forest Baptist surgical oncologist Dr. Edward Levine told The M...
Source: Asbestos and Mesothelioma News - April 13, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

EPA Proposes Asbestos Ban on Chrysotile
The U.S. Environmental Protection Agency proposed a potentially historic ban April 5 that would prohibit all current uses of chrysotile asbestos. Chrysotile is the only known type of asbestos still being imported into the country today. The EPA asbestos ban would prohibit the ongoing importation of raw asbestos along with the manufacturing, processing, distribution and commercial use of products containing chrysotile asbestos. It is being proposed under the Toxic Substances Control Act, which was amended in 2016 and designed to address the safety of existing chemicals. Asbestos is still used in the U.S. today in p...
Source: Asbestos and Mesothelioma News - April 6, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos (general) Source Type: news

Senate Passes Asbestos Awareness Resolution, Inches Closer to Ban
The U.S. Senate unanimously passed its annual National Asbestos Awareness Week resolution, inching closer to long-awaited, much-anticipated legislation to ban the toxic substance. The bipartisan resolution urged the Office of the Surgeon General to warn and better educate citizens about the public health issues of asbestos exposure, the primary cause of mesothelioma cancer. Advocates welcomed the resolution designating April 1-7 as the official Awareness Week, believing more widespread education will increase the likelihood of a legislative ban in the future. “I think the resolution shows unanimous understanding...
Source: Asbestos and Mesothelioma News - April 4, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos (general) Asbestos Exposure Awareness/Advocacy Source Type: news

Past Asbestos Testing on Inmates Could Affect J & J Talc Lawsuits
Johnson & Johnson funded a study more than 50 years ago at a Philadelphia prison that injected asbestos fibers into a small number of inmates to measure the short-term reaction to the toxic mineral when mixed with talc. Details of Johnson & Johnson’s involvement in that study were unsealed for the first time at a trial in 2021, illustrating the company’s long-ago concern over potential problems with asbestos-contaminated talc in several of its products. Bloomberg News first reported the story earlier this month. Legal experts believe the recently uncovered documents could potentially be powerful evidence ...
Source: Asbestos and Mesothelioma News - March 16, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news

$36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana
A Montana District Court jury recently delivered a $36.5 million verdict in a bellwether case that is expected to significantly change the landscape of future litigation involving vermiculite mining and asbestos exposure in Libby, Montana. The jury in Great Falls, Montana, awarded laborer Ralph Hutt $6.5 million in compensatory damages and $30 million in punitive damages in February, dwarfing awards plaintiffs have typically received in the past. Based on a recent Montana Supreme Court decision, the insurance carrier once overseeing the occupational safety program at W.R. Grace & Company, which operated an asbest...
Source: Asbestos and Mesothelioma News - March 3, 2022 Category: Environmental Health Authors: Lynette Zilio Source Type: news

Johnson & Johnson ’ s Talc Bankruptcy Plan Approved
Much to the ire of plaintiff attorneys across the country, a federal judge in New Jersey granted approval for Johnson & Johnson to move forward with its controversial bankruptcy plan involving thousands of talc-related lawsuits. This strategy will allow Johnson & Johnson to split its assets from its liabilities, putting more than 38,000 claims on a newly created entity called LTL Management LLC, which filed for Chapter 11 bankruptcy protection. The lawsuits center around asbestos-contaminated talc and include those for mesothelioma cancer. The majority involve ovarian cancer. United States Bankruptcy Judge...
Source: Asbestos and Mesothelioma News - March 1, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news

Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
This study met its primary endpoint, showing promising clinical activity of abemaciclib in patients with p16ink4A-negative mesothelioma who were previously treated with chemotherapy,” the authors concluded. “[This therapy] warrants further investigation in a randomized study as targeted stratified therapy.” Some patients may have genes that allow a particular response to a drug, such as abemaciclib, but there is still potential to find targets beneficial to other patients. The researchers are interested in adding additional therapy options for patients as the clinical trial continues. Depending on their genetic...
Source: Asbestos and Mesothelioma News - February 28, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news

Former faculty member gives UCLA $10 million to advance ocular genetics research
UCLA has received a $10 million commitment from Dr. Bronwyn Bateman to establish a center for ocular genetics center at the UCLA Stein Eye Institute. The gift will support research projects as well as the center ’s startup costs and greatest needs moving forward.Bateman is a former professor of ophthalmology and pediatrics at the David Geffen School of Medicine at UCLA.“As a long-standing partner of Stein Eye, Bronwyn has helped advance many of our vision programs,” said Dr. Bartly Mondino, UCLA’s Bradley R. Straatsma, M.D. Professor of Ophthalmology and director of the Stein Eye Institute. “We are grateful for t...
Source: UCLA Newsroom: Health Sciences - February 7, 2022 Category: Universities & Medical Training Source Type: news

NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma. It is a long-awaited, much-needed breakthrough. The potential intraoperative adjuvant is a spray-on hydrogel involving genetically engineered molecular nanoparticles designed to specifically target and kill tumor cells. It showed surprising efficacy in a recent laboratory study at the NCI with mesothelioma models in mice. Nature Nanotechnology published the study, detailing the impressive results. “This could be a huge deal, potentially a real game-changer in treating ...
Source: Asbestos and Mesothelioma News - February 1, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news

FDA Looks at Stricter Testing for Asbestos in Talc
The U.S. Food and Drug Administration recently moved a step closer to a much-needed, stricter standardization of testing for the presence of toxic asbestos fibers in talc-containing cosmetic products. On Jan. 13, the FDA released its 124-page consensus document written by the Interagency Working Group on Asbestos in Consumer Products. It outlined a scientific assessment on testing that should better protect the public. Eight U.S. federal agencies, selected by the FDA, were represented in the Interagency Working Group, which began the project in 2018. The burgeoning issue of small amounts of dangerous asbestos in t...
Source: Asbestos and Mesothelioma News - January 18, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news